Dyadic International is a global biotechnology platform company. Co. has developed a gene expression platform for producing commercial quantities of enzymes and other proteins. This technology is based on the Thermothelomyces heterothallica fungus, which Co. named C1. The C1 technology is a fungal expression system for the development and production of enzymes and other proteins. The DYAI stock yearly return is shown above.
The yearly return on the DYAI stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2016 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the DYAI annual return calculation with any dividends reinvested as applicable (on ex-dates).
|